Biosimilar Newsletter Archive

1. 04.18.19 -- 3 Crucial Biosimilar Discussions To Note
   4/18/2019
   04/18/19 Biosimilar Development Newsletter
2. 04.17.19 -- Trends In Bioprocess Development - Top Discussions From Bioprocessing Asia
   4/17/2019
   04/17/19 Biosimilar Development Newsletter
3. 04.12.19 -- Are You Ready For The Changing Biopharma Pipeline?
   4/12/2019
   04/12/19 Biosimilar Development Newsletter
4. 04.11.19 -- Rebates & Biosimilars: Employers Tell All
   4/11/2019
   04/11/19 Biosimilar Development Newsletter
5. 04.04.19 -- Top 4 Takeaways From The BioTech Pharma Summit
   4/4/2019
   04/04/19 Biosimilar Development Newsletter
6. 03.28.19 -- Are Biologics Facing A Buy-And-Bill Renaissance?
   3/28/2019
   03/28/19 Biosimilar Development Newsletter
7. 03.21.19 -- Why These Two Biosimilar Policies Raise Questions
   3/21/2019
   03/21/19 Biosimilar Development Newsletter
8. 03.14.19 -- Biosimilar Success: It's Not That Risky To Attain
   3/14/2019
   03/14/19 Biosimilar Development Newsletter
9. 03.07.19 -- How Can FDA Fix The Biosimilar Pathway?
   3/7/2019
   03/07/19 Biosimilar Development Newsletter
10. 03.05.19 -- Integrating Automation And Data Science To Optimize Process Strategies
    3/5/2019
    03/05/19 Biosimilar Development Newsletter